BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18397216)

  • 1. Chronic high Epstein-Barr viral load carriage in pediatric liver transplant recipients.
    Green M; Soltys K; Rowe DT; Webber SA; Mazareigos G
    Pediatr Transplant; 2009 May; 13(3):319-23. PubMed ID: 18397216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic high Epstein-Barr viral load carriage in pediatric small bowel transplant recipients.
    Lau AH; Soltys K; Sindhi RK; Bond G; Mazariegos GV; Green M
    Pediatr Transplant; 2010 Jun; 14(4):549-53. PubMed ID: 20102529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic and virologic analyses in pediatric liver transplant recipients with chronic high Epstein-Barr virus loads.
    Gotoh K; Ito Y; Ohta R; Iwata S; Nishiyama Y; Nakamura T; Kaneko K; Kiuchi T; Ando H; Kimura H
    J Infect Dis; 2010 Aug; 202(3):461-9. PubMed ID: 20560768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of valacyclovir on Epstein-Barr virus viral loads in pediatric liver transplantation patients.
    Ozçay F; Arslan H; Bilezikçi B; Sevmiş S; Moray G; Haberal M
    Transplant Proc; 2009 Sep; 41(7):2878-80. PubMed ID: 19765462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
    J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and outcome of chronic high Epstein-Barr viral load carriage in pediatric kidney transplant recipients.
    Yamada M; Nguyen C; Fadakar P; Ganoza A; Humar A; Shapiro R; Michaels MG; Green M
    Pediatr Transplant; 2018 May; 22(3):e13147. PubMed ID: 29411474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real-time PCR light cycler.
    Leung E; Shenton BK; Green K; Jackson G; Gould FK; Yap C; Talbot D
    Transpl Infect Dis; 2004 Dec; 6(4):156-64. PubMed ID: 15762933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymptomatic high Epstein-Barr viral load carriage in pediatric renal transplant recipients.
    Tanaka E; Sato T; Ishihara M; Tsutsumi Y; Hisano M; Chikamoto H; Akioka Y; Dohno S; Maeda A; Hattori M; Wakiguchi H; Fujieda M
    Pediatr Transplant; 2011 May; 15(3):306-13. PubMed ID: 21492352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of peripheral blood Epstein-Barr viral load monitoring using polymerase chain reaction in renal transplant recipients.
    Toyoda M; Moudgil A; Warady BA; Puliyanda DP; Jordan SC
    Pediatr Transplant; 2008 Nov; 12(7):778-84. PubMed ID: 18331541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients.
    Lee TC; Savoldo B; Barshes NR; Rooney CM; Heslop HE; Gee AP; Caldwell Y; Scott JD; Goss JA
    Clin Transplant; 2006; 20(3):389-93. PubMed ID: 16824159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained Epstein-Barr virus detection in paediatric liver transplantation. Insights into the occurrence of late PTLD.
    D'Antiga L; Del Rizzo M; Mengoli C; Cillo U; Guariso G; Zancan L
    Liver Transpl; 2007 Mar; 13(3):343-8. PubMed ID: 17154402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of Epstein-Barr viral load in pediatric heart and lung transplant recipients by real-time polymerase chain reaction.
    Benden C; Aurora P; Burch M; Cubitt D; Lloyd C; Whitmore P; Neligan SL; Elliott MJ
    J Heart Lung Transplant; 2005 Dec; 24(12):2103-8. PubMed ID: 16364857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for PTLD in lung and heart-lung transplant recipients by measuring EBV DNA load in bronchoalveolar lavage fluid using real time PCR.
    Michelson P; Watkins B; Webber SA; Wadowsky R; Michaels MG
    Pediatr Transplant; 2008 Jun; 12(4):464-8. PubMed ID: 18466434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus gene expression in the peripheral blood of transplant recipients with persistent circulating virus loads.
    Qu L; Green M; Webber S; Reyes J; Ellis D; Rowe D
    J Infect Dis; 2000 Oct; 182(4):1013-21. PubMed ID: 10979894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr viremia levels after pediatric liver transplantation as measured by real-time polymerase chain reaction.
    Kullberg-Lindh C; Ascher H; Saalman R; Olausson M; Lindh M
    Pediatr Transplant; 2006 Feb; 10(1):83-9. PubMed ID: 16499593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of Epstein-Barr virus load in Argentinean transplant recipients using real-time PCR.
    Yancoski J; Danielian S; Ibañez J; Turconi A; Cuarterolo M; Zelazko M; Niesters Hubert GM
    J Clin Virol; 2004 Sep; 31(1):58-65. PubMed ID: 15288615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-barr virus gene expression, human leukocyte antigen alleles and chronic high viral loads in pediatric renal transplant patients.
    Moran J; Carr M; Waters A; Boyle S; Riordan M; Connell J; Awan A; Hall W; Hassan J
    Transplantation; 2011 Aug; 92(3):328-33. PubMed ID: 21685826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term monitoring of Epstein-Barr virus DNA load and humoral parameter abnormalities in pediatric liver transplant recipients before development of malignancy.
    Gregorek H; Jankowska I; Dzierzanowska-Fangrat K; Teisseyre J; Sawicka A; Kasztelewicz B; Pawłowska J
    Pediatr Transplant; 2010 Aug; 14(5):629-35. PubMed ID: 20158667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-lasting chronic high load carriage of Epstein-Barr virus is more common in young pediatric renal transplant recipients.
    Ladfors SW; Lindahl JK; Hansson S; Brandström P; Andersson R; Jertborn M; Lindh M; Woxenius S; Friman V
    Pediatr Nephrol; 2020 Mar; 35(3):427-439. PubMed ID: 31802220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OKT3 and ganciclovir treatments are possibly related to the presence of Epstein-Barr virus in serum after liver transplantation.
    Barkholt L; Linde A; Falk KI
    Transpl Int; 2005 Jul; 18(7):835-43. PubMed ID: 15948864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.